Neurocrine Biosciences, Inc. (FRA:NB3)
Germany · Delayed Price · Currency is EUR 111.35
-3.00 (-2.62%)
Last updated: Jan 29, 2026, 8:04 AM CET
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €11.42 billion as of January 30, 2026. Its market cap has decreased by -18.60% in one year.
Market Cap
11.42B
Enterprise Value
10.88B
Revenue
2.29B
Ranking
n/a
PE Ratio
31.30
Stock Price
€111.35
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 11.42B, an increase of 6,723.80%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 11.42B | -5.19% |
| Dec 31, 2025 | 12.04B | -9.77% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |